Effects of specific protease inhibitors on amyloid β-protein 42 secretion

Neurobiology of Aging

Volumn 19, Issue SUPPL. 1, 1998, Pages

  Yamazaki, T ^a   Ihara, Y ^a  

^a UNIVERSITY OF TOKYO   (Japan)

Author keywords

Secretase; A 42 ratio; Alzheimer's disease; Amyloid protein; Calpain; Proteasome

Indexed keywords

AMYLOID BETA PROTEIN; AMYLOID PRECURSOR PROTEIN; CALPAIN; PROTEASOME; PROTEINASE INHIBITOR;

ALZHEIMER DISEASE; CELL CULTURE; CONFERENCE PAPER; CONTROLLED STUDY; HUMAN; HUMAN CELL; PRIORITY JOURNAL; PROTEIN SECRETION; PROTEINASE INHIBITION;

ALZHEIMER DISEASE; AMYLOID BETA-PROTEIN; CALPAIN; CELL LINE; CYSTEINE ENDOPEPTIDASES; HUMANS; MULTIENZYME COMPLEXES; PEPTIDE FRAGMENTS; PROTEASE INHIBITORS; PROTEASOME ENDOPEPTIDASE COMPLEX;

EID: 0031969765     PISSN: 01974580     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0197-4580(98)00031-1     Document Type: Conference Paper

References (11)

1. 1 cells. J. Biol. Chem. 270:1995;25115-25120.
2. Figueiredo-Pereira M. E., Banik N., Wilk S. Comparison of the effect of calpain inhibitors on two extralysosomal proteinases The multicatalytic proteinase complex and m-calpain . J. Neurochem. 62:1994;1989-1994.
3. Fukumoto H., Asami-Odaka A., Suzuki N., Shimada H., Ihara Y., Iwatsubo T. Amyloid β protein deposition in normal aging has the same characteristics as that in Alzheimer's disease. Am. J. Pathol. 148:1996;259-265.
4. Haass C., Selkoe D. J. Cellular processing of β-amyloid precursor protein and the genesis of amyloid β-peptide. Cell. 75:1993;1039-1042.
5. Iwatsubo T., Odaka A., Suzuki N., Mizusawa H., Nukina N., Ihara Y. Visualization of Aβ42(43) and Aβ40 in senile plaques with end-specific Aβ monoclonals Evidence that an initially deposited species is Aβ42(43) . Neuron. 13:1994;45-53.
6. Klafki H.-W., Paganetti P. A., Sommer B., Staufenbiel M. Calpain inhibitor I decreases βA4 secretion from human embryonal kidney cells expressing β-amyloid precursor protein carrying the APP670/67 1 double mutation. Neurosci. Lett. 201:1995;29-32.
7. Klafki H.-W., Abramowski D., Swoboda R., Paganetti P. A., Staufenbiel M. The carboxyl termini of β-amyloid peptides 1-40 and 1-42 are generated by distinct γ-secretase activities. J. Biol. Chem. 271:1996;28655-28659.
8. Omura S., Matsuzaki K., Fujimoto T., Kosuge K., Furuya T., Fujita S., Nakagawa A. Structure of lactacystin, a new microbial metabolite which induces differentiation of neuroblastoma cells. J. Antibiot. 44:1991;117-118.
9. Scheuner D., Eckman C., Jensen M., Song X., Citron M., Suzuki N., Bird T. D., Hardy J., Hutton M., Kukull W., Larson E., Levy-Lahad E., Viitanen M., Peskind E., Poorkaj P., Schellenberg G., Tanzi R., Wasco W., Lanfelt L., Selkoe D. J., Younkin S. G. Secreted amyloid β-protein similar to that in the senile plaques of Alzheimer's disease is increased in vivo by the presenilin 1 and 2 and APP mutations linked to familial Alzheimer's disease. Nature Med. 2:1996;864-870.
10. Shinkai Y., Yoshimura M., Ito Y., Odaka A., Suzuki N., Yanagisawa K., Ihara Y. Amyloid β-proteins 1-40 and 1-42 (43) in the soluble fraction of extra- and intracranial blood vessels. Ann. Neurol. 38:1995;421-428.
11. Yamatsuji T., Matsui T., Okamoto T., Komatsuzaki K., Takeda S., Fukumoto H., Iwatsubo T., Suzuki N., Asami-Odaka A., Ireland S., Kinane T. B., Giambarella U., Nishimoto I. G protein-mediated neuronal DNA fragmentation induced by familial Alzheimer's disease-associated mutants of APP. Science. 272:1996;1349-1352.